Advancing Health Equity in Asthma Control through EXHALE Strategies
ID: 347606Type: Posted
Overview

Buyer

Centers for Disease Control - NCEH (HHS-CDC-NCEH)

Award Range

$400K - $725K

Eligible Applicants

Unrestricted

Funding Category

Health

Funding Instrument

Cooperative Agreement

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/347606
Timeline
    Description

    The Centers for Disease Control and Prevention (CDC) is offering a funding opportunity titled "Advancing Health Equity in Asthma Control through EXHALE Strategies," aimed at improving asthma management and health outcomes for underserved populations. Eligible applicants must serve a population of at least 100,000 and implement four of the six EXHALE strategies, which include education on asthma self-management and environmental policy improvements, while also analyzing specific asthma data sets. This initiative addresses significant disparities in asthma prevalence and outcomes, particularly among racial and ethnic minority groups, and emphasizes collaboration with community partners to enhance service delivery. The total estimated program funding is $64 million, with individual awards ranging from $400,000 to $725,000, and applications are due by April 19, 2024. For further inquiries, applicants can contact Eric Morrisey at evm9@cdc.gov.

    Point(s) of Contact
    evm9@cdc.gov
    Files
    Title
    Posted
    CDC-RFA-EH-24-0016-second-FAQ-document-508.pdf
    The document serves as an FAQ for the CDC's funding opportunity under CDC-RFA-EH-24-0016, focusing on asthma control. It clarifies requirements for applicants regarding the level of detail for activities planned for years 2-4 of the funding cycle, emphasizing the necessity of a draft Evaluation and Performance Measurement Plan during application submission. While a strategic evaluation plan is developed post-award with the CDC, the emphasis is placed on merit review results and additional decision-making factors during the selection process. Applicants may receive partial funding based on availability, and previous stipulations regarding modules for childhood asthma prevalence have been reiterated, emphasizing financial planning for module implementation. The document advises against using hyperlinks to external sources in applications but allows for internal bookmarks. Finally, it specifies that evaluation questions should guide the development of objectives in applicants' proposals, reinforcing the collaborative nature of the evaluation plan post-award. This FAQ aims to support applicants in accurately interpreting funding requirements and processes within the context of federal grants for public health initiatives.
    EH-24-0016-FAQ-answers-508.pdf
    The document describes the CDC's funding opportunity (CDC-RFA-EH-24-0016) aimed at advancing health equity in asthma control through EXHALE strategies. Eligible applicants must serve a population of at least 100,000 and regularly analyze specific asthma data sets. The funding allows for one award per state, territory, or Tribal nation, with maximum budget limits linked to jurisdiction populations. Applicants are required to propose and implement four EXHALE strategies, focusing on care coordination and environmental policies, among others. Surveillance requirements emphasize state-level data analysis, especially regarding childhood asthma prevalence. Additional emphasis is placed on collaboration and capacity-building, necessitating at least three letters of collaboration from relevant partners. Guidance on formatting, application structure, and evaluation metrics is also provided, with detailed expectations for project narratives regarding health equity and sustainability. The overall goal is to improve asthma management while enhancing partnerships across multiple sectors to address social determinants of health effectively. This funding opportunity reflects a broader federal commitment to promoting health equity among underserved populations through evidence-based interventions.
    Similar Opportunities
    Advancing the Centers of Excellence in Newcomer Health
    Centers for Disease Control - NCEZID
    The Centers for Disease Control and Prevention (CDC) is forecasting a funding opportunity titled "Advancing the Centers of Excellence in Newcomer Health," aimed at enhancing health outcomes for immigrants and refugees in the United States. This cooperative agreement seeks innovative approaches to outreach and healthcare analysis for at-risk newcomer populations, focusing on areas such as health surveillance, clinical training, and the development of health orientation materials. With an estimated total program funding of $10 million and an award ceiling of $2 million, the CDC anticipates awarding two grants, with applications due by May 2, 2025. Interested applicants, specifically private institutions of higher education, can reach out to the Domestic Team at the Immigrant & Refugee Health Branch via email at IRHBdomestic@cdc.gov or by phone at 800-232-4636 for further information.
    RFA-EH-18-000
    Centers for Disease Control and Prevention - ERA
    The Centers for Disease Control and Prevention (CDC) is offering a federal grant opportunity titled RFA-EH-18-000, aimed at supporting various health-related initiatives through cooperative agreements. Eligible applicants include states, universities, counties, small businesses, and non-profit organizations, who are invited to submit applications for Type 6 Applications as necessary. This funding opportunity is significant for enhancing public health efforts, with an expected total of 100 awards available, although no specific funding amounts have been disclosed. Interested parties should note that the application deadline is October 13, 2025, and can reach out to Linton C Browning at lbrowning@cdc.gov or by phone at 770-488-2756 for further information.
    Assessment and Evaluation of Emerging Health Conditions Relevant to the World Trade Center Health Program (U01)
    Centers for Disease Control and Prevention - ERA
    The Centers for Disease Control and Prevention (CDC) is forecasting a federal grant opportunity titled "Assessment and Evaluation of Emerging Health Conditions Relevant to the World Trade Center Health Program (U01)." This cooperative agreement aims to support research projects that investigate health conditions potentially related to the September 11, 2001, terrorist attacks, focusing on diagnosing and treating conditions that have emerged since the establishment of the WTC Health Program. The initiative is particularly interested in interdisciplinary collaborations that address health equity and the health burdens faced by vulnerable populations exposed to the 9/11 attacks. The estimated total program funding is $33 million, with an award ceiling of $550,000 and approximately 20 awards expected. Interested applicants can reach out to Dr. James Yiin at JYiin@cdc.gov or by phone at 513-841-4271, with applications due by October 28, 2025, and awards anticipated by June 26, 2026.
    Enhancing Public Health Surveillance of Bleeding Disorders
    Centers for Disease Control - NCBDDD
    The Centers for Disease Control and Prevention (CDC) is forecasting a cooperative agreement opportunity titled "Enhancing Public Health Surveillance of Bleeding Disorders." This initiative aims to collect and utilize surveillance data from federally supported hemophilia treatment centers to inform policies and clinical practices related to hemophilia, von Willebrand disease, and other inherited bleeding disorders, ultimately seeking to reduce health complications and improve the quality of life for affected individuals. The program is critical for understanding treatment practices, monitoring health complications, and identifying causes of death among those with bleeding disorders. The estimated total program funding is $21.5 million, with individual awards ranging from $100,000 to $4.3 million. Interested applicants can reach out to Brandi Dupervil at (404) 498-6879 or via email at inm4@cdc.gov, with applications due by May 15, 2025, and an anticipated award date of August 31, 2025.
    Reducing the burden of parasitic infections in the United States through evidence-based prevention and control activities
    Centers for Disease Control - NCEZID
    The Centers for Disease Control and Prevention (CDC) is forecasting a federal grant opportunity aimed at reducing the burden of parasitic infections in the United States through evidence-based prevention and control activities. This initiative, structured as a cooperative agreement, focuses on three key components: enhancing healthcare provider knowledge and practices regarding Chagas disease, expanding public health surveillance for soil-transmitted helminths, and addressing other significant parasitic diseases of domestic concern. With an estimated total program funding of $10 million and an award ceiling of $1 million, the CDC anticipates making approximately seven awards, with applications due by May 2, 2025. Interested applicants can reach out to Emily Dodd at 404-639-3753 or via email at iog2@cdc.gov for further information.
    Asthma and Allergic Diseases Cooperative Research Centers (U19 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is inviting applications for the Asthma and Allergic Diseases Cooperative Research Centers (AADCRC) program, aimed at advancing research on asthma and related allergic conditions. This opportunity seeks proposals from single institutions or collaborative consortia to investigate the mechanisms underlying diseases such as allergic rhinitis, chronic rhinosinusitis, atopic dermatitis, food allergies, and drug allergies, with the goal of enhancing understanding and developing effective treatments and prevention strategies. The program anticipates funding of approximately $6.08 million for FY 2026, with plans to award 4-5 grants, each with a budget limit of $900,000 in direct costs per year. Interested applicants must adhere to NIH guidelines and submit their proposals by June 13, 2025, for further inquiries, they can contact NIH Grants Information at grantsinfo@nih.gov.
    RFA-OE-18-000
    Centers for Disease Control and Prevention - ERA
    The Centers for Disease Control and Prevention (CDC) is offering a federal grant opportunity titled RFA-OE-18-000, aimed at supporting various health-related initiatives through cooperative agreements. Eligible applicants include states, universities, counties, small businesses, and non-profit organizations, with the program designed to facilitate Type 6 Applications as necessary. This funding opportunity is significant for enhancing public health efforts, with an expected total of 100 awards available, although no specific funding amounts have been established. Interested parties should note that applications are due by October 13, 2025, and can direct inquiries to Linton C Browning at lbrowning@cdc.gov or by phone at 770-488-2756.
    RFA-CC-18-000
    Centers for Disease Control and Prevention - ERA
    The Centers for Disease Control and Prevention (CDC) is offering a federal grant opportunity titled RFA-CC-18-000, aimed at supporting Type 6 Applications through cooperative agreements. Eligible applicants include states, universities, counties, small businesses, and non-profit organizations, with no cost-sharing or matching requirements specified. This funding initiative is categorized under health-related activities, with an expected total of 100 awards available, although the award ceiling and floor are both set at zero. Interested parties should note that the application deadline is October 13, 2025, and may contact Linton C. Browning at lbrowning@cdc.gov or by phone at 770-488-2756 for further information.
    RFA-CE-18-000
    Centers for Disease Control and Prevention - ERA
    The Centers for Disease Control and Prevention (CDC) is offering a federal grant opportunity titled RFA-CE-18-000, aimed at supporting various health-related initiatives through cooperative agreements. Eligible applicants include states, universities, counties, small businesses, and non-profit organizations, with the program designed to facilitate Type 6 Applications as necessary. This funding opportunity is significant for enhancing public health efforts, with an expected 100 awards anticipated, although no specific funding amounts have been disclosed. Interested parties should note that the application deadline is October 13, 2025, and can reach out to Linton C Browning at lbrowning@cdc.gov or by phone at 770-488-2756 for further information.
    RFA-PS-18-000
    Centers for Disease Control and Prevention - ERA
    The Centers for Disease Control and Prevention (CDC) is offering a federal grant opportunity titled RFA-PS-18-000, aimed at supporting various health-related initiatives through cooperative agreements. Eligible applicants include states, universities, counties, small businesses, and non-profit organizations, with the program designed to facilitate Type 6 Applications as necessary. This funding opportunity is significant for enhancing public health efforts, with an expected total of 100 awards available. Interested parties should note that there is no cost-sharing requirement, and applications must be submitted by the closing date of October 13, 2025. For further inquiries, applicants can contact Linton C. Browning at lbrowning@cdc.gov or by phone at 770-488-2756.